Todd W Vanderah Selected Research

Pain Management

10/2011	Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.
1/2005	Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd W Vanderah Research Topics

Disease

77	Pain (Aches) 11/2023 - 08/2002
36	Hyperalgesia 10/2023 - 10/2003
25	Neuralgia (Stump Neuralgia) 01/2023 - 06/2002
21	Hypersensitivity (Allergy) 11/2023 - 06/2002
21	Chronic Pain 11/2021 - 01/2005
13	Neoplasms (Cancer) 01/2020 - 01/2005
8	Migraine Disorders (Migraine) 01/2023 - 02/2009
7	Inflammation (Inflammations) 10/2023 - 10/2003
6	Cancer Pain 10/2023 - 06/2003
5	Breast Neoplasms (Breast Cancer) 11/2023 - 10/2011
4	Headache (Headaches) 01/2023 - 02/2009
4	Bone Neoplasms (Bone Cancer) 01/2018 - 11/2007
4	Acute Pain 01/2016 - 05/2006
3	Cognitive Dysfunction 10/2023 - 01/2017
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 10/2021
2	Osteolysis 11/2023 - 11/2007
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2023 - 05/2014
2	Substance-Related Disorders (Drug Abuse) 10/2023 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2019
2	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 01/2020
2	Secondary Headache Disorders 01/2020 - 03/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 04/2015
2	Heart Failure 01/2019 - 01/2017
2	Catalepsy 09/2018 - 04/2010
2	Hypothermia 09/2018 - 04/2010
2	Postoperative Pain 01/2018 - 07/2015
2	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2016
2	Spontaneous Fractures (Pathological Fracture) 10/2011 - 11/2007
2	Peripheral Nerve Injuries 08/2008 - 06/2004
2	Erectile Dysfunction 01/2007 - 06/2003
1	Bone Diseases (Bone Disease) 10/2023

Drug/Important Bio-Agent (IBA)

44	Opioid Analgesics (Opioids)IBA 11/2023 - 08/2002
24	Analgesics (Analgesic Drugs)IBA 11/2023 - 02/2003
23	Morphine (MS Contin)FDA LinkGeneric 11/2023 - 08/2002
12	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023 - 12/2002
10	Opiate AlkaloidsIBA 01/2013 - 01/2005
9	LigandsIBA 01/2016 - 06/2007
9	Dynorphins (Dynorphin)IBA 01/2015 - 06/2002
8	Peptides (Polypeptides)IBA 10/2023 - 06/2007
8	CannabinoidsIBA 01/2023 - 05/2009
6	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021 - 04/2008
6	Opioid Receptors (Opioid Receptor)IBA 03/2020 - 06/2004
6	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2013 - 06/2002
6	Calcitonin Gene-Related PeptideIBA 12/2010 - 04/2008
5	angiotensin I (1-7)IBA 10/2023 - 12/2016
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2012
5	Capsaicin (Zostrix)FDA Link 07/2012 - 10/2003
5	Lidocaine (Xylocaine)FDA LinkGeneric 12/2011 - 06/2002
4	Ion Channels (Ion Channel)IBA 10/2022 - 06/2004
4	Sumatriptan (Imigran)FDA LinkGeneric 01/2020 - 12/2017
4	CB2 Cannabinoid ReceptorIBA 01/2017 - 02/2003
4	AM 1241IBA 03/2012 - 09/2003
4	Cholecystokinin (Pancreozymin)IBA 01/2012 - 01/2005
4	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 06/2011 - 01/2005
3	CarrageenanIBA 10/2023 - 10/2003
3	CalciumIBA 10/2023 - 01/2016
3	EndocannabinoidsIBA 01/2023 - 01/2020
3	EnzymesIBA 01/2023 - 03/2015
3	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2015
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2020 - 09/2017
3	Calcium Channels (Calcium Channel)IBA 01/2020 - 07/2015
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 01/2015
3	SphingolipidsIBA 01/2020 - 09/2017
3	CytokinesIBA 01/2019 - 11/2007
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 06/2012 - 08/2005
2	anandamide (arachidonylethanolamide)IBA 01/2023 - 01/2020
2	PrNMIIBA 10/2022 - 09/2018
2	morpholineIBA 10/2022 - 09/2018
2	Dopamine (Intropin)FDA LinkGeneric 03/2020 - 01/2016
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2020 - 01/2019
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020 - 09/2017
2	Naloxone (Narcan)FDA LinkGeneric 01/2020 - 11/2007
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2020 - 01/2015
2	gamma-Aminobutyric Acid (GABA)IBA 11/2019 - 01/2015
2	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2019 - 11/2013
2	Serotonin (5 Hydroxytryptamine)IBA 11/2019 - 01/2012
2	Small Interfering RNA (siRNA)IBA 01/2019 - 12/2008
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2018 - 01/2010
2	Fentanyl (Sublimaze)FDA LinkGeneric 01/2018 - 12/2013
2	Peroxynitrous Acid (Peroxynitrite)IBA 11/2016 - 04/2015
2	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2015 - 05/2014
2	Substance PIBA 07/2012 - 08/2010
2	AcidsIBA 01/2012 - 02/2003
2	ProstaglandinsIBA 01/2012 - 12/2010
2	Ondansetron (Zofran)FDA LinkGeneric 01/2012 - 05/2007
2	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2010 - 02/2003
2	Cholecystokinin B ReceptorIBA 03/2009 - 01/2005
2	dermorphin-saporinIBA 03/2009 - 06/2002
2	SaporinsIBA 03/2009 - 05/2007
2	Cannabinoid Receptor AgonistsIBA 10/2003 - 02/2003
1	Toll-Like Receptor 4IBA 11/2023
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 11/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023

Therapy/Procedure

33	Therapeutics 10/2023 - 06/2003
9	Ligation 01/2017 - 06/2002
5	Analgesia 10/2021 - 04/2009
2	Drug Therapy (Chemotherapy) 10/2023 - 11/2013
2	Pain Management 10/2011 - 01/2005
2	Oral Administration 03/2009 - 08/2008
2	Spinal Injections 05/2007 - 06/2004